Low dose pralatrexate (PDX) is active in cutaneous T-cell lymphoma: Preliminary results of a multi-center dose finding trial Horwitz, S., Duvic, M., Kim, Y., Chance, L., Myskowski, P., Talpur, R., MORALES, A., Saunders, M., O'Connor, O. OXFORD UNIV PRESS. 2008: 162-162

View details for Web of Science ID 000256693500278